CompuMed licenses DICOM version of its Osteogram software to Orex Computed Radiography

Los Angeles 05 November 2003CompuMed Inc., a medical informatics company serving the health care community with diagnostic software solutions, has signed an agreement to license the DICOM version of its patented OsteoGram software to Orex Computed Radiography Inc. of Yokneam, Israel. Orex has more than 2500 CR systems installed in over 20 countries worldwide.


The OsteoGram is a software-based CAD system that enables health care providers to screen, diagnose and monitor osteoporosis using either a conventional, film-based hand x-ray or an image derived from filmless x-ray equipment. CompuMed recently developed the DICOM version for use with digital radiography systems such as those supplied by Orex, which have become the high growth segment of the medical imaging market. Under the new licensing agreement, CompuMed and Orex will conduct an accelerated clinical trial to validate the OsteoGram on Orex's highly successful Distributed Computed Radiography System (D-CR).

After the trial, the OsteoGram will serve as the bone densitometry CAD component of OREX's CR product offering. The integrated capability of both products will enable users to perform efficient, filmless bone mineral density testing as well as routine digital filmless x-ray imaging using a single compact CR system. The OREX CR images and the OsteoGram reports will be stored digitally in a patient's file as part of a computerized patient database available for retrieval or transmission over a clinic's local area network.

"We are pleased to announce our partnership with Orex, an expert in the global market for computed radiography", stated CompuMed CEO, Jerry McLaughlin. "Our OsteoGram software application can be launched easily on Orex's CR system to enable radiologists, orthopaedic surgeons and other clinicians to seamlessly test for osteoporosis on the same digital x-ray equipment they utilize in their day-to-day practice. The OsteoGram provides an efficient around-the-clock solution with significant savings compared to screening techniques based on expensive and labour-intensive DXA equipment."

Orex Chief Technology Officer Jacob Koren agreed by stating: "Adding such a valuable bone densitometry screening application to the Orex D-CR platform further enhances our ability to provide multiple advanced applications economically and efficiently to all of a health care institution's x-ray rooms."

The National Osteoporosis Foundation (NOF) estimates that one in two women and one in four men will have an osteoporosis-related fracture in her or his lifetime. Osteoporosis is the common underlying factor in most fragility fractures, which are defined as fractures that occur without apparent trauma, or due to a fall from standing height or lower.

Treatment of osteoporosis-related fractures in the United States is estimated to cost $10 to $15 billion annually. This estimate is solely for in-patient care, and does not reflect outpatient costs or indirect costs such as lost wages and productivity. While most osteoporotic fractures occur in the spine, hip and wrist, nearly all fractures in older adults can be attributed at least in part to low bone mass.

"The DICOM version of the OsteoGram is the first in a new suite of applications from CompuMed", stated Jerry McLaughlin. "Future applications and related tools for following the progression of arthritis are also being developed to add value for the end-users of Orex CR systems."

Orex was founded in 1996 as Digident with a focus on developing innovative CR solutions for general dental and orthodontic practices. In 2000, the company was renamed Orex Computerized Radiography with an expanded mission to address the wide range of medical applications for D-CR. Orex is headquartered in Yokneam, Israel, with United States headquarters in Auburndale, Massachusetts.

Founded in 1973, CompuMed Inc. is a provider of computer-aided telemedicine and diagnostics technology. The company's core products are the OsteoGram and CardioGram systems. The OsteoGram, which is cleared by the FDA for commercial use, is an accurate and precise technology for low-cost osteoporosis testing. The CardioGram system remotely interprets electrocardiograms and is used by private practice, government and corporate health care providers nationwide. The CardioGram also has the capability to automatically provide an over-read or follow-up review by a cardiologist. More news on the company is to be found in the VMW September article CompuMed seeks patent protection for new DICOM version of OsteoGram.

Leslie Versweyveld

[Medical IT News][Calendar][Virtual Medical Worlds Community][News on Advanced IT]